Clostridioides difficile is not an outbreak problem – it is an antibiotic problem

Reference: May-June 2026 | Issue 3 | Vol 19 | Page 26

For years, Clostridioides difficile infection (CDI) has been considered a failure of infection control – a hospital-acquired complication best addressed through isolation, enhanced cleaning, and outbreak management. But high-resolution genomic sequencing is forcing a more uncomfortable conclusion ‒ most Clostridioides difficile (C. diff) infection is not caused by hospital spread at all.

The two-year genomic epidemiology study at Letterkenny University Hospital (LUH), serving a predominantly rural population, found that true patient to patient transmission was exceptionally rare. Instead, CDI was driven overwhelmingly by antibiotic exposure, leading to endogenous activation of colonising strains.

Recurrent disease was almost always relapse with the same strain, sometimes persisting for years – a pattern increasingly recognised internationally when whole-genome sequencing is applied.^1,2

While these findings arise from a single hospital, they are unlikely to be unique. In many ways, LUH functions as a sentinel site for Ireland ‒ a health system serving a largely rural population, embedded in agricultural landscapes, and characterised by high antimicrobial consumption.

What genomics reveals – and what it dispels

Using whole-genome sequencing and core-genome multilocus sequence typing, more than 2,100 genetic loci were compared across CDI isolates. This level of resolution allows clinicians to distinguish coincidence from causality in order to determine whether cases are truly linked or merely appear so.¹

Over two years, only one confirmed episode of genuine hospital transmission was identified. Several apparent ‘clusters’ – patients on the same ward with the same sequence type – were shown genomically to be unrelated. Without sequencing, these would almost certainly have been labelled outbreaks.

This matters because misdiagnosing endemic disease as transmission leads to the wrong solutions. It directs attention towards beds and wards, when the real driver lies upstream.

A rural signal with national relevance

The most common strain identified was ST11 (ribotype 078), a lineage strongly associated across Europe with livestock, food chains, and agricultural environments.^2,3 Its repeated detection in unrelated patients, without epidemiological linkage, strongly suggests frequent community acquisition followed by activation during hospitalisation.

Ireland’s population structure makes this especially relevant. Large rural communities, close human-animal contact, and environmental persistence of spores create continuous opportunities for colonisation. Hospitals do not create these strains, they unmask them.

Seen in this light, CDI in Ireland is not primarily a hospital problem. It is a system problem, sitting at the intersection of agriculture, prescribing behaviour, and human biology.

The invisible organ at the centre of it all

At the heart of CDI lies a structure that medicine still struggles to treat with seriousness ‒ the human gut microbiota. Often described as a body ‘organ’ or the ‘second brain’, the gut microbiome weighs 1-2kg ‒ roughly the same as the brain – and contains around 100 trillion microorganisms.⁴ It encodes millions of genes, produces essential metabolites, regulates immune responses, and provides colonisation resistance against pathogens such as C. diff.⁵

From a One Health perspective – a coordinated, holistic strategy designed to sustainably balance and enhance the health of humans, animals, and ecosystems⁶ – the microbiome is where human medicine, veterinary antibiotic use, food systems, and environmental exposure converge biologically. It is also where antimicrobial harm first manifests.

Broad-spectrum antibiotics can collapse microbial diversity within days, eliminating protective species and creating ecological niches that allow dormant C. diff spores to proliferate.⁵ CDI is therefore not an accident, nor a mystery, but rather a predictable ecological failure.

Recovery is slow and often incomplete. Even short antibiotic courses can disrupt the microbiome for months while repeated exposure may cause long-term damage.² This explains why recurrent CDI is usually relapse rather than reinfection ‒ the ecosystem never truly recovers.

CDI should therefore be understood as a sentinel condition and an early warning sign of deeper microbiome injury. The same dysbiosis also facilitates antimicrobial resistance, immune dysfunction, metabolic disease, and vulnerability to other infections.

Antibiotics: The real risk factor

Every CDI case in the LUH cohort had prior antimicrobial exposure. Benchmarking against national data showed persistently high use of CDI-associated antibiotics, including clindamycin, co-amoxiclav, fluoroquinolones, and broad-spectrum penicillins – several in the highest national deciles.

This is not a local aberration. Ireland’s overall antimicrobial consumption remains high by European standards, particularly in acute care.⁷ The lesson is unavoidable ‒ we are prescribing the ecological conditions for CDI into existence.

One Health policy – theory versus practice

Ireland’s National Action Plan on Antimicrobial Resistance explicitly endorses a One Health approach, recognising the interconnected roles of human health, animal health, and the environment.⁸ Yet in practice, CDI prevention remains framed almost exclusively within hospital walls.

Genomic evidence exposes this mismatch. Reducing CDI will not be achieved through isolation rooms alone. It requires:
✽ Sustained reductions in high-risk antimicrobial use
✽ Stewardship programmes with real authority and accountability
✽ Integration of microbiome preservation into prescribing decisions
✽ Recognition that agricultural, environmental, and human antibiotic pressures act on the same biological system.

Without this shift, CDI will continue to recur, not because hospitals are failing to clean properly, but because the system is repeatedly injuring an organ we rarely acknowledge.

Rethinking prevention

Whole-genome sequencing brings clarity. It tells us when outbreaks are real and when they are not. But sequencing cannot prevent disease. Prevention lies upstream, in restraint rather than reaction.

In a country with deep rural roots and close human-environmental ties, Ireland’s CDI burden should prompt a reframing. This is not an infection control failure, but a stewardship failure. Until we treat the microbiome as an organ worth protecting, CDI will remain an entirely predictable consequence of how we practise medicine.